| Ernesto Renteria, MOT | |
|
3700 Gosford Rd Ste G, Bakersfield, CA 93309-7694 | |
| (661) 832-9737 | |
| (661) 832-9738 |
| Full Name | Ernesto Renteria |
|---|---|
| Gender | Male |
| Speciality | Occupational Therapist |
| Location | 3700 Gosford Rd Ste G, Bakersfield, California |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215661434 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | (* (Not Available)) | Primary |
| Provider Name | New Life Physical Therapy Services Pc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1285160788 PECOS PAC ID: 7214207125 Enrollment ID: O20170726001800 |
News Archive
The cell signaling pathway known as Wnt, commonly activated in cancers, causes internal membranes within a healthy cell to imprison an enzyme that is vital in degrading proteins, preventing the enzyme from doing its job and affecting the stability of many proteins within the cell, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism. The results have recently been published in Neuron, one of the most influential journals in the field of neuroscience.
A new collaboration between Seattle Children's Research Institute and bluebird bio, Inc., a biotechnology company based in Cambridge, Mass. and Seattle, will allow researchers to develop potentially transformative gene therapies for severe genetic and rare pediatric diseases. The collaboration supports pediatric researchers in Seattle who will work with bluebird bio scientists and the company's gene editing technology to research potential cures for genetic pediatric diseases.
Researchers have developed a new, rapid biosensor for the early detection of even tiny concentrations of the human influenza A (H1N1) virus.
Following an acute coronary syndrome such as a heart attack or unstable angina, patients who receive a medication to reduce the risk of gastrointestinal bleeding that may be associated with the use of the antiplatelet drug clopidogrel and aspirin have an increased risk of subsequent hospitalization for acute coronary syndrome or death, according to a study in the March 4 issue of JAMA, the Journal of the American Medical Association.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ernesto Renteria, MOT 1201 23rd St, Bakersfield, CA 93301-2306 Ph: (661) 327-4357 | Ernesto Renteria, MOT 3700 Gosford Rd Ste G, Bakersfield, CA 93309-7694 Ph: (661) 832-9737 |
News Archive
The cell signaling pathway known as Wnt, commonly activated in cancers, causes internal membranes within a healthy cell to imprison an enzyme that is vital in degrading proteins, preventing the enzyme from doing its job and affecting the stability of many proteins within the cell, researchers at UCLA's Jonsson Comprehensive Cancer Center have found.
Scientists at VIB and KU Leuven have discovered that the protein APP plays a significant role in the development of fragile X syndrome (FXS) at young stages. They identified an unexpected biological pathway as a promising target to ameliorate deficits associated with FXS and autism. The results have recently been published in Neuron, one of the most influential journals in the field of neuroscience.
A new collaboration between Seattle Children's Research Institute and bluebird bio, Inc., a biotechnology company based in Cambridge, Mass. and Seattle, will allow researchers to develop potentially transformative gene therapies for severe genetic and rare pediatric diseases. The collaboration supports pediatric researchers in Seattle who will work with bluebird bio scientists and the company's gene editing technology to research potential cures for genetic pediatric diseases.
Researchers have developed a new, rapid biosensor for the early detection of even tiny concentrations of the human influenza A (H1N1) virus.
Following an acute coronary syndrome such as a heart attack or unstable angina, patients who receive a medication to reduce the risk of gastrointestinal bleeding that may be associated with the use of the antiplatelet drug clopidogrel and aspirin have an increased risk of subsequent hospitalization for acute coronary syndrome or death, according to a study in the March 4 issue of JAMA, the Journal of the American Medical Association.
› Verified 2 days ago
Mrs. Jenee Busby Sakamoto, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 7737 Meany Ave # B5-7, Bakersfield, CA 93308 Phone: 661-377-1700 Fax: 661-616-9199 | |
Sonia Morales, OTD,OTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 3700 Gosford Rd Ste G, Bakersfield, CA 93309 Phone: 661-326-1433 Fax: 661-326-1032 | |
Michelle Feliciano Daluz, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 3601 San Dimas St, Bakersfield, CA 93301 Phone: 661-323-2894 | |
Willa Overland, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7737 Meany Ave, B5, Bakersfield, CA 93308 Phone: 661-377-1700 Fax: 661-616-9199 | |
Ms. Mary Margaret Martin, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1800 Mount Vernon Ave, Bakersfield, CA 93306 Phone: 661-868-7275 Fax: 661-869-2726 | |
Danielle Marie Moon, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4101 Easton Dr, Bakersfield, CA 93309 Phone: 661-377-1700 Fax: 661-616-9199 | |
Megan Grace Cotter, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 7737 Meany Ave Ste B5, Bakersfield, CA 93308 Phone: 661-377-1700 Fax: 661-616-9199 |